Sunday, December 23, 2012

FDA and States Meet On Regulation of Drug Compounders

F.D.A. and States Meet About Regulation of Drug Compounders - NYTimes.com:

"Pharmacies fall primarily under state law, and the F.D.A. convened the meeting to get specifics from states on gaps in the regulatory net and how the states see the federal role. Some states said they would prefer to see the F.D.A. handle large-scale compounders like the New England Compounding Center, or N.E.C.C., the Massachusetts pharmacy that was the source of the outbreak.

“The consensus in our group was that there is a role for the F.D.A. to be involved in facilities like N.E.C.C.,” said Cody Wiberg, the executive director of the Minnesota Board of Pharmacy. “If you’re talking about compounding, most states have the authority and resources to handle that. If you’re talking about nontraditional compounding,” he said, referring to large-scale enterprises like N.E.C.C., “fewer states may have the resources to do that.”"

'via Blog this'

Return Home:  The Designated Representative and Exemptee Blog

CA Designated Representative online training certification - for Drug Wholesalers
FL Designated Representative online exam preparation - for Drug Wholesalers

CA HMDR Exemptee online web-based training certification by SkillsPlus Intl Inc.
SkillsPlus Intl Info Blog
Enhanced by Zemanta


Custom Search

From SkillsPlus International Inc.